Forcing Taxpayers to Bankroll Ozempic While Ignoring the Poison in Our Food: Congress's Tone-Deaf Betrayal
Originally published: 2025-08-29
In a nation where nearly three-quarters of adults are overweight or obese, and childhood obesity rates are skyrocketing, you'd think our elected officials would prioritize fixing the broken food system that's fueling this crisis. Instead, over 100 members of Congress are rallying behind a bill to expand Medicare coverage for drugs like Ozempic, essentially asking American taxpayers to foot a multi-trillion-dollar bill for a pharmaceutical "fix" that treats symptoms while ignoring the root cause: the toxic, ultra-processed foods poisoning our children.
This isn't just misguided policy; it's a outrageous display of tone-deafness, where lawmakers, many padded by Big Pharma donations, choose profits over prevention. Robert F. Kennedy Jr. nailed it in his fiery critique, and it's time we amplify the outrage.
RFK Jr.'s Scathing Indictment: Stop Poisoning Our Kids
RFK Jr., the environmental advocate and health crusader now influencing policy in the Trump administration, didn't mince words in a widely shared video from late 2024. Speaking out against the push to subsidize Ozempic through Medicare, he declared:
"Today, over 100 members of Congress support a bill to fund Ozempic with Medicare. How about we just stop poisoning our children with toxic food that makes them obese??"
His point? Extending coverage to all obese Americans, about 74% of the population, could cost taxpayers up to $3 trillion annually. For half that amount, we could provide regeneratively raised organic food for every American, three meals a day, plus gym memberships. This aligns with his "Make America Healthy Again" (MAHA) initiative, which blasts agricultural subsidies for flooding school lunches and food stamps with GMO-laden junk, creating "lifetime customers" for the medical-industrial complex.
RFK Jr. accuses bill supporters of being bought off by Novo Nordisk, the Danish giant behind Ozempic, whose lobbying has ballooned its valuation to Europe's largest company. It's a damning charge: legislators are tone-deaf to the cries of families struggling with obesity, opting instead for a quick pharma payout that burdens the very taxpayers they're sworn to protect.
The Bill: A Tone-Deaf Handout to Big Pharma
The legislation in question is the Treat and Reduce Obesity Act (TROA), reintroduced in the 119th Congress as H.R. 4231 in the House and S. 1973 in the Senate. Sponsored by bipartisan figures like Rep. Raul Ruiz (D-CA) and Sen. Bill Cassidy (R-LA), it expands Medicare Part D to cover anti-obesity medications like Ozempic (semaglutide) for weight loss, not just diabetes. As of August 2025, the bills are in committee, building on the previous Congress's H.R. 4818, which boasted 120 cosponsors.
Proponents claim it could save lives and cut long-term healthcare costs, but critics see it as a giveaway to Novo Nordisk, fueled by millions in lobbying dollars.What's truly infuriating is the hypocrisy. While the Trump administration announced in April 2025 that Medicare and Medicaid won't cover these drugs starting in 2026, echoing RFK Jr.'s prevention-first stance, the bill's backers persist. They're tone-deaf to the fiscal cliff: estimates peg the annual cost in the hundreds of billions, exploding to trillions if fully expanded. Why force hardworking Americans to subsidize a drug that masks the damage from a food system rigged by corporate interests? It's not compassion; it's corruption.
The Dark Side of Ozempic: A Laundry List of Horrors
Ozempic isn't the miracle it's marketed as, it's a double-edged sword with side effects that can devastate lives. According to the FDA's black box warning, it carries a risk of thyroid C-cell tumors, based on rodent studies. Common complaints include nausea, vomiting, diarrhea, abdominal pain, and constipation, affecting up to 15-20% of users. But the serious risks are where the outrage boils over: pancreatitis, gallbladder issues like cholecystitis, kidney failure, and severe gastrointestinal problems such as gastroparesis (stomach paralysis) and ileus (intestinal blockage).
"Gastrointestinal symptoms — nausea, vomiting, diarrhea, and constipation — are by far the most common side effects of GLP-1 drugs."
Long-term horrors include "Ozempic face" (rapid facial aging from muscle and fat loss), vision changes, and even reports of suicidal ideation in some GLP-1 drugs. Legislators pushing taxpayer funding for this are tone-deaf to the human cost, real people suffering debilitating, sometimes irreversible harm, all while Big Pharma rakes in billions.
Mounting Legal Battles: Thousands Demand Justice from Novo Nordisk
The lawsuits piling up against Novo Nordisk scream volumes about Ozempic's dangers. As of August 2025, over 2,000 to 2,600 cases are consolidated in Multidistrict Litigation (MDL) No. 3094 in the Eastern District of Pennsylvania, with numbers climbing monthly. Plaintiffs allege the company failed to adequately warn about risks like gastroparesis, ileus, intestinal obstruction, vision loss, and gallbladder removal.
"As of August 2025, more than 1,800 Ozempic lawsuits have been consolidated into MDL No. 3094... with the number expected to grow."
These aren't frivolous claims; they're from victims who've endured emergency surgeries, permanent disabilities, and life-altering pain. No settlements yet, but bellwether trials loom in 2026, potentially costing Novo Nordisk billions. It's enraging that Congress wants to use your tax dollars to prop up a drug facing such massive legal scrutiny, tone-deaf doesn't even begin to cover it.
The Staggering Cost: Trillions Down the Drain
Beyond the health risks, the financial burden is obscene. RFK Jr. estimates full coverage could hit $3 trillion yearly, dwarfing investments in preventive measures like organic farming or food system reform. Even partial expansion under TROA could add hundreds of billions to Medicare's tab. In a time of ballooning national debt, why are legislators so eager to saddle taxpayers with this?
The answer: Novo Nordisk's lobbying machine, which has funneled millions to influence policy. This tone-deaf priorities put pharma profits ahead of fiscal sanity and public health.
A Better Way Forward: Prevention Over Pills
RFK Jr. offers a radical yet sensible alternative: Redirect funds to eliminate toxic foods from our supply chain. Ban GMOs in school meals, subsidize regenerative agriculture, and promote real nutrition education. The Trump admin's 2025 decision to block coverage is a step in the right direction, but we need more. It's time to hold legislators accountable, demand they ditch this pharma handout and tackle the obesity crisis at its source.In the end, this isn't about one drug or bill; it's about a system that's profoundly broken. By ignoring RFK Jr.'s call to "stop poisoning our children," Congress isn't just tone-deaf, they're complicit in perpetuating a national tragedy. Taxpayers deserve better.
